Ph2/3 BMS-986545 + Chemo vs Nivolumab + Chemo in Gastric GEJ or Esophageal

Phase II/III Clinical Trial

ROSETTA Gastric-204: A Blinded Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Nivolumab in Combination with Chemotherapy in Participants with Previously Untreated Advanced or Metastatic Gastric Gastroesophageal Junction or Esophageal Adenocarcinoma - CA266-0004

Indication: Esophageal Cancer, Gastric Cancer

Trial Number: 07221149

Trial Status: OPEN

Learn more about this clinical trial.

Ph2/3 BMS-986545 + Chemo vs Nivolumab + Chemo in Gastric GEJ or Esophageal

Phase II/III Clinical Trial

Loading component...

Ph2/3 BMS-986545 + Chemo vs Nivolumab + Chemo in Gastric GEJ or Esophageal

Phase II/III Clinical Trial